ACE2 as therapy for pulmonary arterial hypertension: the good outweighs the bad - Archive ouverte HAL Access content directly
Journal Articles European Respiratory Journal Year : 2018

ACE2 as therapy for pulmonary arterial hypertension: the good outweighs the bad

(1, 2) , (3) , (1, 4)
1
2
3
4

Abstract

no abstract

Domains

Life Sciences [q-bio] Life Sciences [q-bio] Human health and pathology Life Sciences [q-bio] Human health and pathology Pulmonology and respiratory tract Life Sciences [q-bio] Human health and pathology Endocrinology and metabolism Life Sciences [q-bio] Human health and pathology Cardiology and cardiovascular system Life Sciences [q-bio] Human health and pathology Urology and Nephrology Life Sciences [q-bio] Santé publique et épidémiologie

Christophe Guignabert  : Connect in order to contact the contributor

https://www.hal.inserm.fr/inserm-02582393

Submitted on : Thursday, May 14, 2020-9:41:08 PM

Last modification on : Monday, October 17, 2022-1:38:25 PM

Consult the full text

Dates and versions

inserm-02582393 , version 1 (14-05-2020)

Identifiers

Cite

Christophe Guignabert, Frances S de Man, Marc M. Lombès. ACE2 as therapy for pulmonary arterial hypertension: the good outweighs the bad. European Respiratory Journal, 2018, 51 (6), pp.1800848. ⟨10.1183/13993003.00848-2018⟩. ⟨inserm-02582393⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

INSERM UNIV-PARIS-SACLAY GS-HEALTH-DRUG-SCIENCES PHYSENDO
43 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More